Canada - TSX:TMD - CA88830X8199 - Common Stock
The current stock price of TMD.CA is 0.8 CAD. In the past month the price decreased by -29.2%. In the past year, price increased by 841.18%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 250.00M | ||
| MIR.CA | MEDMIRA INC | N/A | 56.87M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 47.59M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 47.08M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 27.91M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 23.17M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 19.52M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.53M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 16.77M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 3.98M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| IDL.CA | IMAGING DYNAMICS CO LTD | N/A | 413.20K |
Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
TITAN MEDICAL INC
76 Berkeley Street
TORONTO ONTARIO M5H 3B7 CA
CEO: David J. McNally
Employees: 4
Phone: 14165487522
Conavi Medical Corp is a CA-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
The current stock price of TMD.CA is 0.8 CAD. The price decreased by -4.76% in the last trading session.
TMD.CA does not pay a dividend.
TMD.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
TMD.CA stock is listed on the Toronto Stock Exchange exchange.
You can find the ownership structure of TITAN MEDICAL INC (TMD.CA) on the Ownership tab.
ChartMill assigns a technical rating of 7 / 10 to TMD.CA. When comparing the yearly performance of all stocks, TMD.CA is one of the better performing stocks in the market, outperforming 99.94% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TMD.CA. The financial health of TMD.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months TMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS increased by 65.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -111.81% | ||
| ROE | -184.94% | ||
| Debt/Equity | 0.22 |